From Hit to Lead to Drug Candidate: Medicinal Chemistry that Drives Impact

With nearly a decade of experience in small-molecule drug discovery, I support early-stage therapeutic programs through thoughtful design, clear strategy, and collaborative execution. My work spans the full discovery pipeline, helping teams navigate complexity and move confidently toward candidate nomination.

CHEMISTRY LEADERSHIP
I have led 7 drug discovery programs, with recognized expertise in CNS drug design.

  • Apply structure-based design, lead optimization, and asset selection to advance high-quality compounds

  • Collaborate closely with computational chemists, pharmacologists, and DMPK experts

  • Focus on delivering molecules with scientific rigor and clinical intent

END-TO-END DISCOVERY EXECUTION

  • Target validation and early feasibility

  • Target engagement and pharmacological confirmation

  • In vivo proof-of-concept

  • Build structured project plans with clear milestones and cross-functional coordination

INNOVATION WITH REAL WORL RESULTS 

  • Co-inventor on 10 patents

  • Contributed to a program that reached Phase 2 clinical trials

  • Helped enable the launch of a new biotech company based on early discovery success

STRATEGIC INSIGHT AND DUE DILIGENCE

  • Provide clear, data-driven input on technical assessments and development strategies

  • Support opportunity evaluation, risk analysis, and go/no-go decisions

  • Help shape early-stage decisions that drive long-term value

Whether you're building a new program or strengthening an existing one, I bring the insight, execution, and strategy needed to turn early discovery into real therapeutic opportunity.

Translating Science into Strategy: Venture & BD Support

I help early-stage ventures, academic teams, and innovation hubs navigate the path from discovery to opportunity. Drawing on my experience in startup acceleration, scientific assessment, and cross-functional collaboration, I offer strategic support that bridges science and execution.

VENTURE & STARTUP ENABLEMENT

  • Support preclinical strategy, IP planning, and milestone definition
  • Coach teams on scientific storytelling, pitch development, and value creation
  • Contributed to the growth of startups including 9Bio Therapeutics, TATUM Bioscience, and RejuvenRx 

 

STRATEGIC ASSESSMENT & PARTNERSHIPS

  • Conduct technical assessments, opportunity evaluations, and due-diligence
  • Help define value propositions and support partnering conversations
  • Translate complex science into clear, compelling narratives for investors and collaborators

Let’s turn promising science into strategic momentum and measurable outcomes.